Skip to main content
letter
. 2018 Jan;103(1):e1–e4. doi: 10.3324/haematol.2017.176065

Figure 1.

Figure 1.

Kaplan-Meier failure analysis. Values are number of patients at risk at the corresponding time point and in brackets the number of deferiprone-related adverse drug reactions during the respective 6-month period (only first occurrence considered per patient). Censored observation markers and exposure after 60 months have been omitted for the sake of curve simplicity.